ELEVANCE HEALTH, INC. vs Oscar Health, Inc., two Managed Care stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where ELV and OSCR diverge most: on revenue growth, ELV reads +6.5% and OSCR reads +40.9%; on fcf yield, ELV reads 7.0% and OSCR reads 39.4%. The rest of the comparable metrics sit closer together. What ELV's price implies is a bet that sits within the historical range (earnings-power basis). The bull and bear cases for each are in their full reports below.
| Metric | ELV | OSCR |
|---|---|---|
| Price | $412.51 | $33.37 |
| Market cap | $89.9B | $11.1B |
| Sector | Managed Care | Managed Care |
| Stage | Mature | Growth |
| P/E | 18.3 | 23.0 |
| P/B | 2.00 | 5.41 |
| P/S | 0.45 | 0.73 |
| EV/EBITDA | 17.7 | 11.4 |
| Revenue growth | +6.5% | +40.9% |
| Operating margin | 3.5% | 8.0% |
| Net margin | 2.5% | 3.6% |
| Return on equity | 11.0% | 26.8% |
| Return on assets | 3.9% | 4.9% |
| Return on invested capital | 5.4% | 24.7% |
| FCF yield | 7.0% | 39.4% |
| Dividend yield | 1.4% | — |
| Debt / equity | 0.69 | 0.21 |
| Current ratio | 1.52 | 1.08 |
| Altman Z (solvency) | 2.92 | 2.00 |
| Piotroski F (quality) | 7 / 9 | 6 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.